Clinical Trials Logo
  1. Home
  2. Pancreatitis, Acute
  3. NCT06178172

Remote Home Monitoring in Mild Acute Pancreatitis — INTERACT  

Pancreatitis, Acute Clinical Trial

Official title:
Implementation of a Remote Home Monitoring Program for Patients With a Mild Acute Pancreatitis - A Single Center Feasibility Study

Clinical Trial Summary

Acute pancreatitis is an inflammation of the pancreas which causes abdominal pain and is the most common gastro-intestinal reason for acute hospitalization in Western countries. Because care for patients with a mild acute pancreatitis is mostly supportive, providing this care in the home environment may be feasible with the use of remote monitoring. This might reduce the demand for hospital beds and allow patients to benefit from recovering in their home environment. Therefore, the objective of this single center study is to assess the feasibility of a novel care program in which patients with a predicted mild course of acute pancreatitis are discharged early with remote home monitoring. Patients, with a predicted mild course of acute pancreatitis. Patients with prior acute pancreatitis within 3 months or a chronic pancreatitis are excluded from participation. Patients should be ≥18 years of age. The goal is to include a total of 70 patients. After at least 48 hours of hospital admission, patients are discharged early with the use of remote home monitoring. At home, patients receive guidance for the management of pain, nutrition and pancreatitis-related complaints by a daily phone call from a nurse from the Virtual Monitoring Centre (VMC). The pancreatitis-related complaints, intake of fluids and food, pain and the use of analgesics are assessed using short questionnaires in a smartphone app. Core temperature is monitored using an ear thermometer and a wearable sensor measures heart rate, respiratory rate, posture and movement every 5 minutes. Remote home monitoring will continue for at least 4 days. The main study objective is to assess the feasibility of the novel care program. Feasibility is determined by, patient satisfaction and actual use of the novel care program. The secondary study objective is to describe clinical outcomes of patients in the novel care program.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06178172
Study type Interventional
Source Rijnstate Hospital
Contact
Status Not yet recruiting
Phase N/A
Start date January 2, 2024
Completion date October 2, 2025
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT03609944 - SpHincterotomy for Acute Recurrent Pancreatitis N/A
Recruiting NCT05572788 - Rectal Indomethacin to Prevent Acute Pancreatitis in EUS-FNA of Pancreatic Cysts N/A
Completed NCT03642769 - Lactated Ringer's Versus Normal Saline for Acute Pancreatitis N/A
Active, not recruiting NCT05095831 - EUS Shear Wave for Solid Pancreatic Lesions.
Completed NCT04570852 - Acute Pancreatitis Targets (APT) Study N/A
Recruiting NCT03686618 - Secretin for Acute Pancreatitis Phase 2
Not yet recruiting NCT03740685 - Changes in High Sensitive C Reactive Protien With Different Treatment Modalities in Acute Pancreatitis
Not yet recruiting NCT04037449 - Transversus Abdominis Plane Block in the Analgesia of Acute Pancreatitis N/A
Completed NCT03342716 - Resolution of Organ Injury in Acute Pancreatitis - RESORP
Not yet recruiting NCT03342807 - Intravenous Administration of Insulin and Plasma Exchange on Triglyceride Levels in Early Stage of Hypertriglyceridemia-induced Pancreatitis Phase 4
Not yet recruiting NCT04760847 - Intermittent Fasting for Pancreatitis N/A
Terminated NCT02959112 - Epinephrine Sprayed on the Papilla Versus Sterile Water Sprayed on the Papilla for Preventing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography N/A
Recruiting NCT05381428 - Prophylaxis of Post-ERCP Acute Pancreatitis Phase 3
Active, not recruiting NCT05955235 - A Long-term Safety Follow-up Study of SCM-AGH in Patients Who Completed SCM-APT2001 Study
Recruiting NCT05160506 - Corticosteroids to Treat Pancreatitis Phase 2
Not yet recruiting NCT03082469 - Pancreatitis CytoSorbents (CytoSorb®) Inflammatory Cytokine Removal Phase 4
Completed NCT03672422 - Pediatric Longitudinal Cohort Study of Chronic Pancreatitis
Completed NCT00490386 - Helicobacter Pylori and Acute Alcohol Induced Pancreatitis N/A
Completed NCT04188990 - Cost Effectiveness of an Intervention in Hospitalized Patients With Disease-related Malnutrition N/A
Active, not recruiting NCT04743323 - A Case-CrossovEr Study deSign to Inform Tailored Interventions to Prevent Disease Progression in Acute Pancreatitis